Pathway Genomics – CancerIntercept® Detect

CancerIntercept® Detect is a blood-based non-invasive test that can be used by physicians for the detection of circulating tumor DNA (ctDNA). Presence of increased levels of ctDNA and of the distinct mutations in the covered driver genes has been seen in many cancer types when disease is developing or is present. This test works by analyzing cell-free DNA (cfDNA). It detects the presence of specific genomic markers called circulating tumor DNA (ctDNA) in 9 cancer driver genes.

We have not reviewed this DNA test yet. If you have taken this test, please scroll down and click “Add your review.” All DNA tests that have not been reviewed receive a default score of 6/10 until reader reviews change the score.

CancerIntercept? Detect is a blood-based non-invasive test that can be used by physicians for the detection of circulating tumor DNA (ctDNA). Presence of increased levels of ctDNA and of the distinct mutations in the covered driver genes has been seen in many cancer types when disease is developing or is present. This test works by analyzing cell-free DNA (cfDNA). It detects the presence of specific genomic markers called circulating tumor DNA (ctDNA) in 9 cancer driver genes.

$299 - $699

TAKE THE TEST